Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.
Agarwal S, Fang L, McGowen K, Yin J, Bowman J, Ku AT, Alilin AN, Corey E, Roudier MP, True LD, Dumpit R, Coleman I, Lee JK, Nelson PS, Capaldo BJ, Mariani A, Hoover C, Senatorov IS, Beshiri M, Sowalsky AG, Hurt EM, Kelly K.
Agarwal S, et al. Among authors: bowman j.
J Clin Invest. 2023 Nov 15;133(22):e162148. doi: 10.1172/JCI162148.
J Clin Invest. 2023.
PMID: 37725435
Free PMC article.